The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma
Abstract Background Inflammation and the immune system significantly impact the development, progression, and treatment response of hepatocellular carcinoma (HCC). This retrospective study investigated the neutrophil‐to‐lymphocyte ratio (NLR) as a prognostic biomarker in Western patients with HCC in...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-08-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.3573 |
id |
doaj-ebeddeb203ff408e9028b0dd753e1503 |
---|---|
record_format |
Article |
spelling |
doaj-ebeddeb203ff408e9028b0dd753e15032021-08-16T11:21:35ZengWileyCancer Medicine2045-76342021-08-0110165395540410.1002/cam4.3573The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinomaCortlandt M. Sellers0Johannes Uhlig1Johannes M. Ludwig2Jeffrey S. Pollak3Tamar H. Taddei4Stacey M. Stein5Joseph K. Lim6Hyun S. Kim7Section of Interventional Radiology Department of Radiology and Biomedical Imaging Yale University School of Medicine New Haven CT USASection of Interventional Radiology Department of Radiology and Biomedical Imaging Yale University School of Medicine New Haven CT USASection of Interventional Radiology Department of Radiology and Biomedical Imaging Yale University School of Medicine New Haven CT USASection of Interventional Radiology Department of Radiology and Biomedical Imaging Yale University School of Medicine New Haven CT USASection of Digestive Diseases Department of Internal Medicine Yale University School of Medicine New Haven CT USASection of Medical Oncology Department of Internal Medicine Yale University School of Medicine New Haven CT USASection of Digestive Diseases Department of Internal Medicine Yale University School of Medicine New Haven CT USASection of Interventional Radiology Department of Radiology and Biomedical Imaging Yale University School of Medicine New Haven CT USAAbstract Background Inflammation and the immune system significantly impact the development, progression, and treatment response of hepatocellular carcinoma (HCC). This retrospective study investigated the neutrophil‐to‐lymphocyte ratio (NLR) as a prognostic biomarker in Western patients with HCC in the setting of chronic viral hepatitis. Methods Patients diagnosed with HCC from 2005 to 2016 were selected from a tertiary care institution. NLR was calculated within 30 days prior to treatment and dichotomized at the median. Kaplan–Meier overall survival (OS) curves and Cox hazard proportional models were utilized. Tumor and liver reserve parameters were included in multivariable analyses (MVA). Results A total of 581 patients met inclusion criteria (median age 61.0 yr; 78.3% male; 66.3% Caucasian) with median OS = 34.9 mo. 371 patients (63.9%) had viral hepatitis, of which 350 had hepatitis C (94.3%). The low‐NLR group (<median NLR = 2.45) demonstrated higher median OS of 45.6 mo versus the high‐NLR group (median OS 23.9 mo, p < 0.0001). Log‐transformed NLR was associated with decreased OS, after multivariable adjustment for confounders (hazard ratio [HR] = 1.34, p = 0.0033). Viral hepatitis was identified as an NLR effect modifier: in nonviral hepatitis (n = 210), low NLR was associated with higher median OS versus high NLR (56.7 mo vs. 17.6 mo, p < 0.0001). This was decreased in viral hepatitis (n = 371) (low vs. high NLR: 41.9 mo vs. 35.2 mo, p = 0.0109). Further, the interaction term between hepatitis and log‐transformed NLR was significant (p = 0.0274) on MVA. Conclusions Lower baseline NLR was associated with increased overall survival in HCC. Viral hepatitis serves as an effect modifier of NLR, attenuating its prognostic relevance in this hepatitis C‐predominant population.https://doi.org/10.1002/cam4.3573hepatitis Ccarcinomahepatocellularinflammationneutrophilslymphocytes |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Cortlandt M. Sellers Johannes Uhlig Johannes M. Ludwig Jeffrey S. Pollak Tamar H. Taddei Stacey M. Stein Joseph K. Lim Hyun S. Kim |
spellingShingle |
Cortlandt M. Sellers Johannes Uhlig Johannes M. Ludwig Jeffrey S. Pollak Tamar H. Taddei Stacey M. Stein Joseph K. Lim Hyun S. Kim The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma Cancer Medicine hepatitis C carcinoma hepatocellular inflammation neutrophils lymphocytes |
author_facet |
Cortlandt M. Sellers Johannes Uhlig Johannes M. Ludwig Jeffrey S. Pollak Tamar H. Taddei Stacey M. Stein Joseph K. Lim Hyun S. Kim |
author_sort |
Cortlandt M. Sellers |
title |
The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma |
title_short |
The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma |
title_full |
The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma |
title_fullStr |
The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma |
title_full_unstemmed |
The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma |
title_sort |
effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma |
publisher |
Wiley |
series |
Cancer Medicine |
issn |
2045-7634 |
publishDate |
2021-08-01 |
description |
Abstract Background Inflammation and the immune system significantly impact the development, progression, and treatment response of hepatocellular carcinoma (HCC). This retrospective study investigated the neutrophil‐to‐lymphocyte ratio (NLR) as a prognostic biomarker in Western patients with HCC in the setting of chronic viral hepatitis. Methods Patients diagnosed with HCC from 2005 to 2016 were selected from a tertiary care institution. NLR was calculated within 30 days prior to treatment and dichotomized at the median. Kaplan–Meier overall survival (OS) curves and Cox hazard proportional models were utilized. Tumor and liver reserve parameters were included in multivariable analyses (MVA). Results A total of 581 patients met inclusion criteria (median age 61.0 yr; 78.3% male; 66.3% Caucasian) with median OS = 34.9 mo. 371 patients (63.9%) had viral hepatitis, of which 350 had hepatitis C (94.3%). The low‐NLR group (<median NLR = 2.45) demonstrated higher median OS of 45.6 mo versus the high‐NLR group (median OS 23.9 mo, p < 0.0001). Log‐transformed NLR was associated with decreased OS, after multivariable adjustment for confounders (hazard ratio [HR] = 1.34, p = 0.0033). Viral hepatitis was identified as an NLR effect modifier: in nonviral hepatitis (n = 210), low NLR was associated with higher median OS versus high NLR (56.7 mo vs. 17.6 mo, p < 0.0001). This was decreased in viral hepatitis (n = 371) (low vs. high NLR: 41.9 mo vs. 35.2 mo, p = 0.0109). Further, the interaction term between hepatitis and log‐transformed NLR was significant (p = 0.0274) on MVA. Conclusions Lower baseline NLR was associated with increased overall survival in HCC. Viral hepatitis serves as an effect modifier of NLR, attenuating its prognostic relevance in this hepatitis C‐predominant population. |
topic |
hepatitis C carcinoma hepatocellular inflammation neutrophils lymphocytes |
url |
https://doi.org/10.1002/cam4.3573 |
work_keys_str_mv |
AT cortlandtmsellers theeffectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma AT johannesuhlig theeffectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma AT johannesmludwig theeffectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma AT jeffreyspollak theeffectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma AT tamarhtaddei theeffectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma AT staceymstein theeffectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma AT josephklim theeffectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma AT hyunskim theeffectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma AT cortlandtmsellers effectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma AT johannesuhlig effectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma AT johannesmludwig effectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma AT jeffreyspollak effectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma AT tamarhtaddei effectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma AT staceymstein effectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma AT josephklim effectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma AT hyunskim effectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma |
_version_ |
1721205823442518016 |